- 专利标题: Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
-
申请号: US11138083申请日: 2005-05-25
-
公开(公告)号: US09597395B2公开(公告)日: 2017-03-21
- 发明人: John K. Fraser , Marc H. Hedrick , Min Zhu , Brian M. Strem , Eric Daniels , Isabella Wulur
- 申请人: John K. Fraser , Marc H. Hedrick , Min Zhu , Brian M. Strem , Eric Daniels , Isabella Wulur
- 申请人地址: US CA San Diego
- 专利权人: Cytori Therapeutics, Inc.
- 当前专利权人: Cytori Therapeutics, Inc.
- 当前专利权人地址: US CA San Diego
- 代理机构: Knobbe Martens Olson & Bear LLP
- 主分类号: C12N5/00
- IPC分类号: C12N5/00 ; A61K45/06 ; C12N5/077 ; A61K35/28
摘要:
Adipose derived regenerative cells are used to treat patients, including patients with cardiovascular conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells, e.g., stem and/or progenitor cells, obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, adipose derived regenerative cells are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic cardiovascular benefit.